C12N 2710/24144
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2710/24144 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 6 US grants and 14 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 14
- Assignees
- 10
- Inventors
- 29
- Latest grant
- 25 Jun 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 1 | 2 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 1 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
| 2025 | 0 | 2 |
By publication year.
Recent patents
- Delivery and use of the CRISPR-CAS systems, vectors and compositions for hepatic targeting and therapy25 Jun 2024US 12,018,275 B2Massachusetts Institute of Technology
- Immunostimulatory compositions and uses therefor29 Mar 2022US 11,285,191 B2Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
- Delivery and use of the CRISPR-Cas systems, vectors and compositions for hepatic targeting and therapy3 Mar 2020US 10,577,630 B2Massachusetts Institute of Technology
- Methods and compositions for the production of recombinant virus vectors11 Sep 2012US 8,263,396 B2
- Packaging of positive-strand RNA virus replicon particles25 Apr 2006US 7,034,141 B2Wyeth Holdings Corporation
- Reverse genetics system for feline morbillivirus2 Oct 2025US 2025/0304921 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Delivery and use of the crispr-cas systems, vectors and compositions for hepatic targeting and therapy27 Mar 2025US 2025/0101468 A1Massachusetts Institute of Technology
- Producer Viruses for Generation of Retroviruses In Situ14 Jul 2022US 2022/0220505 A1KaliVir Immunotherapeutics, Inc.
- Neural stem cell compositions including chimeric poxviruses for cancer treatment25 Feb 2021US 2021/0052660 A1City of Hope
- Delivery and use of the crispr-cas systems, vectors and compositions for hepatic targeting and therapy17 Dec 2020US 2020/0392541 A1Massachusetts Institute of Technology
Most cited
By later US patents
- Delivery and use of the CRISPR-Cas systems, vectors and compositions for hepatic targeting and therapy60US 10,577,630 B2Massachusetts Institute of Technology · 2020
- Equine infectious anemia virus vectors18US 6,312,683 B1Oxford Biomedica (UK) Limited · 2001
- Packaging of positive-strand RNA virus replicon particles3US 7,034,141 B2Wyeth Holdings Corporation · 2006
- Methods and compositions for the production of recombinant virus vectors3US 8,263,396 B22012
- Delivery and use of the CRISPR-CAS systems, vectors and compositions for hepatic targeting and therapy1US 12,018,275 B2Massachusetts Institute of Technology · 2024